The Increasing Problem of Wound Bacterial Burden and Infection in Acute and Chronic Soft-tissue Wounds Caused by Methicillin-resistant Staphylococcus Aureus
Overview
Authors
Affiliations
Unlabelled: Methicillin-resistant Staphylococcus aureus (MRSA) has become a leading cause of colonization and infection in both acute and chronic soft-tissue wounds.
Objective: Our objective is to define this current epidemic problem caused by both community-acquired MRSA (CA-MRSA) and hospital-acquired MRSA (HA-MRSA), focusing on the similarities and differences between these 2 isolates as well as the impact on wound management decisions.
Methods: Methods used include a literature review on the growth of the current MRSA problem and its International scope. In addition, a current up-to-date assessment had been made of the problem and the current approach to management of MRSA in acute soft-tissue and chronic wounds. Burns are not discussed because this injury usually does not fit either categories and is managed quite uniquely.
Results: Results included the following: (1) There are very distinct properties of CA-MRSA and HA-MRSA, which must be considered for acute and chronic wound care. Management of both requires rigorous barrier precaution techniques to avoid cross-contamination. The presence of MRSA as a carrier state increases the risk of both a systemic and local wound infection in the carrier. There are large and increasing reservoirs of CA-MRSA and HA-MRSA worldwide leading to more bacteremias and wound problems. Topical antimicrobial therapy has not been addressed in managing MRSA in acute and chronic wounds.
Conclusion: Conclusions include the fact that both HA-MRSA and CA-MRSA wound infections are rapidly increasing, especially with CA-MRSA. This high incidence requires appropriate wound prediction and management decisions as well as attempts to avoid further cross-contamination and reservoir growth. Topical antimicrobial therapy would seem to be an important component in controlling this tremendous problem. Yet this topic has yet to be adequately addressed.
Nguyen-Huu C, Cao T, Nguyen V Glob Pediatr Health. 2024; 11:2333794X241283785.
PMID: 39315057 PMC: 11418239. DOI: 10.1177/2333794X241283785.
Bacterial Interactions in the Context of Chronic Wound Biofilm: A Review.
Durand B, Pouget C, Magnan C, Molle V, Lavigne J, Dunyach-Remy C Microorganisms. 2022; 10(8).
PMID: 35893558 PMC: 9332326. DOI: 10.3390/microorganisms10081500.
Roman J, Fuenmayor C, Zuluaga Dominguez C, Clavijo-Grimaldo D, Acosta M, Garcia-Castaneda J RSC Adv. 2022; 9(35):20432-20438.
PMID: 35514725 PMC: 9065569. DOI: 10.1039/c9ra03643a.
Infection control measures in nosocomial MRSA outbreaks-Results of a systematic analysis.
Pannewick B, Baier C, Schwab F, Vonberg R PLoS One. 2021; 16(4):e0249837.
PMID: 33826678 PMC: 8026056. DOI: 10.1371/journal.pone.0249837.
Bacterial Cellulose: Functional Modification and Wound Healing Applications.
He W, Wu J, Xu J, Mosselhy D, Zheng Y, Yang S Adv Wound Care (New Rochelle). 2020; 10(11):623-640.
PMID: 32870775 PMC: 8392072. DOI: 10.1089/wound.2020.1219.